Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$15.00
0.75 NAPNAP contact hour, of which0.5 is Pharmacology, 0.5 Psychopharmacology and 0.25 is Controlled substance. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $7.5 for NAPNAP Members. For non- members, this continuing education activity rate is $15. The purpose of this session is to provide the pediatric-focused APRN with an introduction to the use and effects of cannabis on children and youth. The discussion includes a conversation about the current cannabis laws, the physiologic effects of cannabis, the evidence for cannabis use in pediatrics and guideline for facilitating discussions with families who have interest in using cannabis for their children. This session is appropriate for providers from all patient care settings and for the novice to seasoned APRN.
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP contact hour, of which 1.0 is Pharmacology and 1.0 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide the participant with up-to-date information about commonly used antidepressants and atypical antipsychotics.
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP contact hour, of which 0.5 is Pharmacology and 0.5 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.5 for NAPNAP Members. For non- members, this continuing education activity rate is $25. This session will focus on the increased prevalence of anxiety and depression in children and adolescents in our post-COVID society. The lack of available child psychology and psychiatry services has increased the role of pediatric-focused NPs in providing evidence-based treatment of young patients with these diagnoses throughout the pandemic. Using case-based scenarios and interactive technology, participants will discuss factors impacting symptom presentation and review pharmacologic and non-pharmacologic treatment strategies. Innovative, COVID-friendly mental health resources and coping strategies for children, adolescents and their families will be presented.
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$35.00
1.75 NAPNAP contact hour, of which 1.75 is Pharmacology and 1.75 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $17.5 for NAPNAP Members. For non- members, this continuing education activity rate is $35. This presentation reviews the neurological/biological basis and treatment of psychiatric conditions common to children and adolescents. The presenters will cover the basic anatomy and physiology of the brain to guide a neurological review of common pediatric psychiatric conditions. This knowledge is then used to discuss the pharmacological treatment of psychiatric conditions in the clinical setting.
  • Primary Care
  • Acute Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
$90.00
5.25 NAPNAP Contact Hours, 3.75 Pharmacology, 3.75 Psychopharmacology and 0.25 is Controlled substance. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $42 for NAPNAP Members. For non- members, this continuing education activity rate is $90. The bundle will provide a closer look on Neuropsychiatric Medications and The Application in Pediatric Practice , Psychotropic Medications, Effects of Cannabis on Children and Adolescents, Anxiety and Depression through the Waves of COVID-19, and Racial/Ethnic Disparities in Mental Health.
  • Primary Care
  • FREE for Members
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
  • Contact hours
$10.00
0.5 contact hour of which 0.5 contain pharmacology content and 0.5 controlled substances.This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. Urine drug screening (UDS) is a laboratory test frequently used to screen for drugs of abuse, monitor for medication compliance, evaluate for suspected drug intoxication or overdose, and in office-based pain contracts (Kale, 2019; Standridge, Adams, & Zotos, 2010). In children and adolescents, UDS may be used to prevent substance use, evaluate for suspected drug use or intoxication, or as part of substance abuse treatment (Levy & Siqueira, 2014). When using UDS as a tool to make clinical decisions about high-risk medications, it is important to understand the differences between UDS testing modalities, common causes of falsepositive or false-negative results, and the detection window of specific medications. There are two commonly used types of UDS available: immunoassay and gas chromatography/ mass spectrometry (GC-MS; Kale, 2019).